跳至主要内容
临床试验/ACTRN12614000907640
ACTRN12614000907640终止未知

Do adolescents with major depressive disorder (MDD) who receive left-sided, high frequency transcranial magnetic stimulation (TMS) experience reduction in depressive symptoms more than those adolescents with MDD who are given right sided TMS.

Monash Health0 个研究点目标入组 14 人开始时间: 2014年8月26日最近更新:
适应症

试验速览

阶段
未知
状态
终止
发起方
Monash Health
入组人数
14

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
13 Years 至 18 Years(—)
性别
All

入选标准

  • adolescents with a current DSM-IV diagnosis of Major Depressive Disorder diagnosed by a trained clinician using the Kiddie-SADS-Present and Lifetime Version and scores above 45 on the Children's Depression Rating Scale Revised.

排除标准

  • Patient who have had Electroconvulsive Therapy (ECT) in the current episode of depression are excluded. Diagnoses of schizophrenia, bipolar affective disorder, intellectual disability, restrictive eating disorder, autism, drug dependence, epilepsy, any neurosurgical procedure severe medical illness (such as heart disease), metal in the cranium, pacemaker, cochlear implant, patients who have medication pump or other electronic device, or pregnant women are all excluded from this study.

研究者

发起方
Monash Health

相似试验

An Evaluation of Repetitive Transcranial Magnetic... | 临床试验